Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • Nov. 09, 2024, 03:32 UTC
  • 58
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Precigen Inc (PGEN)

  • Technical Exchange News
  • Nov. 09, 2024, 03:31 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 53
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Nov. 09, 2024, 03:30 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • Nov. 08, 2024, 19:30 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Precigen Inc (PGEN)

  • Technical Exchange News
  • Nov. 08, 2024, 19:29 UTC
  • 53
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 08, 2024, 19:27 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 08, 2024, 19:27 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text
  • Previous
  • 669
  • 670
  • 671
  • 672
  • 673
  • Next

Search

News categories

  • Technical Exchange News(14408)
  • Event(6229)
  • SEC News(376045)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(229748)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin